NASDAQ:PRTK

Paratek Pharmaceuticals News Headlines

$8.01
-0.11 (-1.35 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.86
Now: $8.01
$8.13
50-Day Range
$6.84
MA: $7.48
$8.40
52-Week Range
$3.81
Now: $8.01
$8.75
Volume247,586 shs
Average Volume473,046 shs
Market Capitalization$375.61 million
P/E RatioN/A
Dividend YieldN/A
Beta1.62

Headlines

Paratek Pharmaceuticals (NASDAQ PRTK) News Headlines Today

SourceHeadline
Paratek Pharmaceuticals (NASDAQ:PRTK) Downgraded to "Sell" at Zacks Investment ResearchParatek Pharmaceuticals (NASDAQ:PRTK) Downgraded to "Sell" at Zacks Investment Research
marketbeat.com - March 16 at 3:28 AM
-$0.22 Earnings Per Share Expected for Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) This Quarter-$0.22 Earnings Per Share Expected for Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) This Quarter
americanbankingnews.com - April 14 at 6:44 PM
Paratek (PRTK) Moves 14.5% Higher: Will This Strength Last?Paratek (PRTK) Moves 14.5% Higher: Will This Strength Last?
finance.yahoo.com - April 12 at 6:48 PM
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK): Is Breakeven Near?Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK): Is Breakeven Near?
finance.yahoo.com - April 12 at 1:48 PM
Stock Traders Buy Large Volume of Call Options on Paratek Pharmaceuticals (NASDAQ:PRTK)Stock Traders Buy Large Volume of Call Options on Paratek Pharmaceuticals (NASDAQ:PRTK)
americanbankingnews.com - April 9 at 8:52 PM
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Expected to Announce Quarterly Sales of $32.83 MillionParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) Expected to Announce Quarterly Sales of $32.83 Million
americanbankingnews.com - March 30 at 11:58 AM
Paratek Pharmaceuticals (PRTK) Q4 2020 Earnings Call TranscriptParatek Pharmaceuticals (PRTK) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 25 at 3:24 AM
Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Misses Revenue EstimatesParatek Pharmaceuticals (PRTK) Reports Q4 Loss, Misses Revenue Estimates
nasdaq.com - February 24 at 10:23 PM
Paratek Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call PresentationParatek Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 24 at 7:54 PM
Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 MillionParatek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
finance.yahoo.com - February 24 at 5:22 PM
Paratek Pharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceParatek Pharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 18 at 6:50 PM
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
finance.yahoo.com - February 17 at 6:00 PM
Some Analysts Just Cut Their Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) EstimatesSome Analysts Just Cut Their Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Estimates
finance.yahoo.com - February 10 at 8:24 AM
Paratek Announces Expansion of NUZYRA(R) Launch into the Community SettingParatek Announces Expansion of NUZYRA(R) Launch into the Community Setting
marketwatch.com - February 8 at 10:13 AM
Paratek Announces Expansion of NUZYRA® Launch into the Community SettingParatek Announces Expansion of NUZYRA® Launch into the Community Setting
finance.yahoo.com - February 8 at 10:13 AM
Paratek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual ConferenceParatek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference
finance.yahoo.com - January 6 at 12:57 PM
Paratek Pharma Secures $60M Loan To Repay Hercules CapitalParatek Pharma Secures $60M Loan To Repay Hercules Capital
nasdaq.com - January 5 at 8:22 AM
Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC GroupParatek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group
finance.yahoo.com - January 4 at 6:02 PM
How Much Did Paratek Pharmaceuticals(NASDAQ:PRTK) Shareholders Earn From Share Price Movements Over The Last Five Years?How Much Did Paratek Pharmaceuticals'(NASDAQ:PRTK) Shareholders Earn From Share Price Movements Over The Last Five Years?
finance.yahoo.com - December 25 at 3:07 PM
Notable Monday Option Activity: PRTK, WBA, CTASNotable Monday Option Activity: PRTK, WBA, CTAS
nasdaq.com - December 21 at 7:38 PM
Is PRTK A Good Stock To Buy Now?Is PRTK A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 2:23 AM
Paratek Pharmaceuticals: 100%+ Upside As Nuzyra Sales ScaleParatek Pharmaceuticals: 100%+ Upside As Nuzyra Sales Scale
seekingalpha.com - December 1 at 4:35 PM
News for Paratek Pharmaceuticals IncNews for Paratek Pharmaceuticals Inc
markets.businessinsider.com - November 16 at 5:47 PM
Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare ConferenceParatek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 12 at 5:36 PM
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Analysts Are Pretty Bullish On The Stock After Recent ResultsParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) Analysts Are Pretty Bullish On The Stock After Recent Results
nasdaq.com - November 9 at 12:39 PM
Paratek Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call PresentationParatek Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call Presentation
seekingalpha.com - November 6 at 7:56 PM
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q3 2020 Results - Earnings Call TranscriptParatek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 5:50 PM
Paratek Pharmaceuticals EPS beats by $0.15, beats on revenueParatek Pharmaceuticals EPS beats by $0.15, beats on revenue
seekingalpha.com - November 5 at 8:03 PM
Paratek Pharmaceuticals, Inc. to Host Earnings CallParatek Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 3:02 PM
Paratek Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020Paratek Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020
finance.yahoo.com - October 27 at 8:54 AM
What Kind Of Investors Own Most Of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)?What Kind Of Investors Own Most Of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)?
finance.yahoo.com - October 26 at 5:55 PM
Paratek Pharmaceuticals Presenting New Data on NUZYRA® (Omadacycline) at IDWeek 2020Paratek Pharmaceuticals Presenting New Data on NUZYRA® (Omadacycline) at IDWeek 2020
finance.yahoo.com - October 21 at 8:24 AM
Paratek Pharmaceuticals: Undervalued Antibiotics Play With A Fighting ChanceParatek Pharmaceuticals: Undervalued Antibiotics Play With A Fighting Chance
seekingalpha.com - September 17 at 11:00 PM
Market Sentiment Around Loss-Making Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)Market Sentiment Around Loss-Making Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)
finance.yahoo.com - August 25 at 12:51 PM
Paratek Pharmaceuticals, Inc.(PRTK) CEO Evan Loh on Q2 2020 Results - Earnings Call TranscriptParatek Pharmaceuticals, Inc.(PRTK) CEO Evan Loh on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 10 at 8:12 PM
Recap: Paratek Pharmaceuticals Q2 EarningsRecap: Paratek Pharmaceuticals Q2 Earnings
benzinga.com - August 10 at 3:12 PM
Paratek Pharmaceuticals EPS misses by $0.47, misses on revenueParatek Pharmaceuticals EPS misses by $0.47, misses on revenue
seekingalpha.com - August 10 at 10:11 AM
Paratek Pharmaceuticals Announces Second Quarter 2020 Total Revenue of $9.3 Million including NUZYRA® (omadacycline) Net Revenue of $8.1 MillionParatek Pharmaceuticals Announces Second Quarter 2020 Total Revenue of $9.3 Million including NUZYRA® (omadacycline) Net Revenue of $8.1 Million
finance.yahoo.com - August 10 at 10:11 AM
Paratek Pharmaceuticals (PRTK) Reports Q2 Loss, Lags Revenue EstimatesParatek Pharmaceuticals (PRTK) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 10:11 AM
Paratek Pharmaceuticals to Present at Two August 2020 Healthcare ConferencesParatek Pharmaceuticals to Present at Two August 2020 Healthcare Conferences
finance.yahoo.com - August 5 at 8:46 PM
Paratek Pharmaceuticals (PRTK) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseParatek Pharmaceuticals (PRTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - August 4 at 12:48 AM
Paratek Pharmaceuticals (PRTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseParatek Pharmaceuticals (PRTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - August 3 at 2:48 PM
Paratek Pharmaceuticals Announces the Submission of the pre-Emergency Use Authorization Application to the FDA for NUZYRA•Paratek Pharmaceuticals Announces the Submission of the pre-Emergency Use Authorization Application to the FDA for NUZYRA•
www.bloomberg.com - August 2 at 12:57 AM
Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for All FDA Required Post-marketing Studies for NUZYRA•Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for All FDA Required Post-marketing Studies for NUZYRA•
www.bloomberg.com - August 2 at 12:57 AM
Paratek Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 10, 2020Paratek Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 10, 2020
finance.yahoo.com - July 28 at 6:16 PM
Will Paratek Pharmaceuticals (PRTK) Report Negative Q2 Earnings? What You Should KnowWill Paratek Pharmaceuticals (PRTK) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 28 at 1:15 PM
Edited Transcript of PRTK earnings conference call or presentation 11-May-20 12:30pm GMTEdited Transcript of PRTK earnings conference call or presentation 11-May-20 12:30pm GMT
finance.yahoo.com - June 5 at 10:55 PM
Paratek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of StockholdersParatek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of Stockholders
finance.yahoo.com - May 29 at 12:42 PM
Paratek Pharmaceuticals to Present at Jefferies 2020 Virtual Healthcare ConferenceParatek Pharmaceuticals to Present at Jefferies 2020 Virtual Healthcare Conference
finance.yahoo.com - May 28 at 11:34 AM
Paratek Plods AlongParatek Plods Along
seekingalpha.com - May 14 at 12:22 AM
Paratek Pharmaceuticals, Inc. (PRTK)Paratek Pharmaceuticals, Inc. (PRTK)
uk.finance.yahoo.com - May 11 at 9:00 PM
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.